Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03314688 · ClinicalTrials.gov registry record · NA
Lifestyle, Exercise, and Nutrition Study Early After Diagnosis
A NA study of Breast Neoplasms, sponsored by Yale University.
- Active
- Registry status
- NA
- Development phase
- 173
- Enrollment target
- 2
- Study locations
NCT03314688: Active NA study of Breast Neoplasms, sponsored by Yale University.
NCT03314688 is a NA study of Breast Neoplasms that is active but no longer recruiting, run by Yale University. The registered enrollment target is 173 participants, below the 567-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03314688, a NA study of Breast Neoplasms, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 173 participants
- Enrollment target
- 2
- Study locations
Study Summary
The proposed study is a randomized trial evaluating the impact of a dietary and physical activity guidelines intervention vs. usual care on adherence to breast cancer treatments, body composition, and changes in biomarkers in 172 women newly diagnosed with breast cancer scheduled to receive neoadjuvant or adjuvant chemotherapy.
Primary Outcome
Chemotherapy completion rate will be assessed (via medical records) as the average relative dose-intensity (RDI) for the originally planned regimen based on standard formulas. RDI is calculated by dividing the participant's actual dose by the planned dose to get a percentage of actual dose/planned dose.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Dietary/Physical Activity intervention
Study Locations (2)
Connecticut
- Yale University - New Haven
Massachusetts
- Dana Farber Cancer Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What the registry record for NCT03314688 still lists
NCT03314688 is an interventional study that assigns participants to a tested intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap, below the 567-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Breast Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT03314688 reports a single indexed study location in Connecticut, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03314688 about?
NCT03314688 is a clinical study titled "Lifestyle, Exercise, and Nutrition Study Early After Diagnosis". The proposed study is a randomized trial evaluating the impact of a dietary and physical activity guidelines intervention vs. usual care on adherence to breast cancer treatments, body composition, and changes in biomarkers in 172 women newly diagnosed with breast cancer scheduled to receive neoadjuv...
What is the current status of trial NCT03314688?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 173 participants. The study started on 2018-01-02. Estimated completion is 2026-07-31.
What conditions does trial NCT03314688 study?
This clinical trial studies the following conditions: Breast Neoplasms.
What interventions are being tested in trial NCT03314688?
The interventions under investigation include: Usual Care (BEHAVIORAL), Dietary/Physical Activity intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03314688?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03314688 being conducted?
This trial has 2 study locations across Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03314688's enrollment target sits among peer trials
173 43rd of 97 higher than 55 of 97 other Breast Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Breast Cancer, Reasoning, and Activity Intervention
RECRUITING · NA
-
Biennial CEM in Women With a Personal History of Breast Cancer
RECRUITING · NA
-
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
RECRUITING · NA
-
Dissemination of BREASTChoice AIM1-B
RECRUITING · NA
-
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
ACTIVE NOT RECRUITING · NA
-
Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05568719 · 173 participants · Phase 3
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- NCT07070115 · 173 participants · NA
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
- NCT07150832 · 173 participants · NA
Efficacy of the I-CARE Digital Health Intervention
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI